These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1217 related items for PubMed ID: 27141983

  • 21. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice.
    Youl PH, Janda M, Aitken JF, Del Mar CB, Whiteman DC, Baade PD.
    Br J Dermatol; 2011 Jul; 165(1):35-43. PubMed ID: 21443534
    [Abstract] [Full Text] [Related]

  • 22. Skin Cancers in Medicare Beneficiaries With Actinic Keratoses.
    Mohr C, Li Y, Navsaria LJ, Hinkston CL, Shete SS, Margolis DJ, Wehner MR.
    JAMA Dermatol; 2023 Dec 01; 159(12):1368-1372. PubMed ID: 37938822
    [Abstract] [Full Text] [Related]

  • 23. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
    Philipp-Dormston WG, Müller K, Novak B, Strömer K, Termeer C, Hammann U, Glutsch JW, Krähn-Senftleben G, Lübbert H, Koller M, Szeimies RM, NMSC-QoL Study Group.
    J Eur Acad Dermatol Venereol; 2018 Jul 01; 32(7):1138-1146. PubMed ID: 29150868
    [Abstract] [Full Text] [Related]

  • 24. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A, Kaufman KL, Ali M, Arthur J, Kossard S, Fernandez-Penas P.
    J Dermatol Sci; 2018 Jul 01; 91(1):69-78. PubMed ID: 29665991
    [Abstract] [Full Text] [Related]

  • 25. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
    van der Leest RJT, Hollestein LM, Liu L, Nijsten T, de Vries E.
    J Eur Acad Dermatol Venereol; 2018 Mar 01; 32(3):382-389. PubMed ID: 28898461
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Risk of skin cancer following tamoxifen treatment in more than 16,000 breast cancer patients: a cohort study.
    Praestegaard C, Kjaer SK, Andersson M, Steding-Jensen M, Frederiksen K, Mellemkjaer L.
    Breast Cancer; 2016 Nov 01; 23(6):908-916. PubMed ID: 26660140
    [Abstract] [Full Text] [Related]

  • 28. Histology of melanoma and nonmelanoma skin cancer.
    Müller CS.
    Adv Exp Med Biol; 2014 Nov 01; 810():141-59. PubMed ID: 25207364
    [Abstract] [Full Text] [Related]

  • 29. HIPK2 expression in progression of cutaneous epithelial neoplasm.
    Kwon MJ, Min SK, Seo J, Kim DH, Sung CO, Lim MS, Cho J, Park HR.
    Int J Dermatol; 2015 Mar 01; 54(3):347-54. PubMed ID: 25711204
    [Abstract] [Full Text] [Related]

  • 30. Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer.
    Osterlind A, Hou-Jensen K, Møller Jensen O.
    Br J Cancer; 1988 Sep 01; 58(3):385-91. PubMed ID: 3179192
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Epidemiology of skin cancer in the mature patient.
    Lai V, Cranwell W, Sinclair R.
    Clin Dermatol; 2018 Sep 01; 36(2):167-176. PubMed ID: 29566921
    [Abstract] [Full Text] [Related]

  • 33. Dermatoscopic findings and dermatopathological correlates in clinical variants of actinic keratosis, Bowen's disease, keratoacanthoma, and squamous cell carcinoma.
    Ertop Doğan P, Akay BN, Okçu Heper A, Rosendahl C, Erdem C.
    Dermatol Ther; 2021 May 01; 34(3):e14877. PubMed ID: 33583118
    [Abstract] [Full Text] [Related]

  • 34. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
    Zaravinos A, Kanellou P, Spandidos DA.
    Br J Dermatol; 2010 Feb 01; 162(2):325-31. PubMed ID: 19849697
    [Abstract] [Full Text] [Related]

  • 35. Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient.
    Peters S, Bouchaab H, Zimmerman S, Bucher M, Gaide O, Letovanec I, Homicsko K, Michielin O.
    Melanoma Res; 2014 Oct 01; 24(5):496-500. PubMed ID: 25185693
    [Abstract] [Full Text] [Related]

  • 36. Neoplastic skin lesions in the elderly patient.
    Farage MA, Miller KW, Berardesca E, Maibach HI.
    Cutan Ocul Toxicol; 2008 Oct 01; 27(3):213-29. PubMed ID: 18988090
    [Abstract] [Full Text] [Related]

  • 37. Epidemiological and pathological aspects of skin cancer in North East of Romania.
    Andrese E, Solovăstru LG, Taranu T, Iancu LS.
    Rev Med Chir Soc Med Nat Iasi; 2014 Oct 01; 118(2):457-62. PubMed ID: 25076715
    [Abstract] [Full Text] [Related]

  • 38. Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
    Vanneste L, Wolter P, Van den Oord JJ, Stas M, Garmyn M.
    J Eur Acad Dermatol Venereol; 2015 Jan 01; 29(1):61-8. PubMed ID: 24661317
    [Abstract] [Full Text] [Related]

  • 39. Quantitative assessment of Langerhans cells in actinic keratosis, Bowen's disease, keratoacanthoma, squamous cell carcinoma and basal cell carcinoma.
    McArdle JP, Knight BA, Halliday GM, Muller HK, Rowden G.
    Pathology; 1986 Apr 01; 18(2):212-6. PubMed ID: 3763243
    [Abstract] [Full Text] [Related]

  • 40. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    Erlendsson AM, Egekvist H, Lorentzen HF, Philipsen PA, Stausbøl-Grøn B, Stender IM, Haedersdal M.
    Int J Dermatol; 2016 Mar 01; 55(3):309-16. PubMed ID: 26276415
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.